Skip to main content

Table 1 Select characteristics of providers participating in quantitative survey phase (n = 78)

From: Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study

Characteristics

Frequency

%

Age (n = 66)

Mean (SD)

40.9

12.0

Race*

White

55

70.5

Asian

9

11.5

Other Race

7

9.0

Black or African American

3

3.8

Ethnicity (n = 70)

Not Hispanic or Latino/a/x

66

94.3

Hispanic or latino/a/x

4

5.7

Degree*

Doctor of Medicine (MD)

61

78.2

Nurse Practitioner (NP)

7

9.0

Doctor of Osteopathic Medicine (DO)

5

6.4

Master of Public Health (MPH)

5

6.4

Physician Assistant (PA)

4

5.1

Doctor of Philosophy (PhD)

4

5.1

Registered Nurse (RN)

3

3.8

Master of Science (MS)

3

3.8

Specialty*

Internal medicine

37

47.4

Addiction medicine

27

34.6

Emergency medicine

14

18.0

Infectious disease

9

11.5

Psychiatry

7

9.0

Other**

6

7.7

Addiction psychiatry

3

3.8

Dermatology

3

3.8

Pediatrics

2

2.6

Years treating patients with SU/SUD (n = 71)

Mean (SD)

8.2

9.4

Harm reduction acceptance (n = 72)***

Favorable attitude towards harm reduction

70

97.2

Favorable attitude towards abstinence

2

2.8

  1. SU/SUD Substance Use/Substance Use Disorder
  2. *Will not sum to 100%, as providers were able to select multiple choices
  3. **Includes Opthalmology, Rheumatology, Family Medicine, Anesthesia, and HIV
  4. ***Our modified Harm Reduction Acceptability scale contained 13 items in which participants indicated their level of agreement for each item on a scale of 1 (strongly agree) to 5 (strong disagree). Some questions are reverse scored. A mean score of less than 3 suggests a favorable attitude toward harm reduction. A mean score greater than three suggests a favorable attitude towards abstinence